Cited by

• New markers of bone and collagen turnover in children and adults with growth hormone deficiency.

  Sartorio A, Conti A, Monzani M. Sartorio A, et al. Postgrad Med J. 1993 Nov;69(817):846-50. doi: 10.1136/pgmj.69.817.846. Postgrad Med J. 1993. PMID: 8290428 Free PMC article.
• Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field.

  Sartorio A, Marazzi N, Agosti F, Faglia G, Corradini C, De Palo E, Cella S, Rigamonti A, Muller EE. Sartorio A, et al. J Endocrinol Invest. 2004 May;27(5):410-5. doi: 10.1007/BF03345283. J Endocrinol Invest. 2004. PMID: 15279071
• Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.

  Sartorio A, Conte G, Conti A, Masala A, Alagna S, Rovasio P, Faglia G. Sartorio A, et al. J Endocrinol Invest. 2000 Jun;23(6):356-61. doi: 10.1007/BF03343738. J Endocrinol Invest. 2000. PMID: 10908162
• Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment.

  Terzolo M, Piovesan A, Osella G, Pia A, Reimondo G, Pozzi C, Raucci C, Torta M, Paccotti P, Angeli A. Terzolo M, et al. Calcif Tissue Int. 1993 Mar;52(3):188-91. doi: 10.1007/BF00298716. Calcif Tissue Int. 1993. PMID: 8481830
• Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.

  Sartorio A, Ortolani S, Galbiati E, Conte G, Vangeli V, Arosio M, Porretti S, Faglia G. Sartorio A, et al. J Endocrinol Invest. 2001 Apr;24(4):224-30. doi: 10.1007/BF03343851. J Endocrinol Invest. 2001. PMID: 11383908